Trials / Completed
CompletedNCT00051142
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and IOP-lowering efficacy of Travoprost (0.004%) compared to Latanoprost (0.005%) in patients with chronic open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost | |
| DRUG | Latanoprost |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2004-06-01
- Completion
- 2004-06-01
- First posted
- 2003-01-07
- Last updated
- 2008-08-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00051142. Inclusion in this directory is not an endorsement.